You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

NEOSTIGMINE METHYLSULFATE - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for neostigmine methylsulfate and what is the scope of freedom to operate?

Neostigmine methylsulfate is the generic ingredient in three branded drugs marketed by Exela Pharma, Am Regent, Amneal, Amphastar Pharms Inc, Amring Pharms, Be Pharms, Caplin, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Indoco, Meitheal, Nivagen Pharms Inc, Par Sterile Products, Sagent Pharms Inc, and Avet Lifesciences, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for neostigmine methylsulfate. Twenty-six suppliers are listed for this compound.

Summary for NEOSTIGMINE METHYLSULFATE

US Patents:	0
Tradenames:	3
Applicants:	18
NDAs:	20
Drug Master File Entries:	9
Finished Product Suppliers / Packagers:	26
Raw Ingredient (Bulk) Api Vendors:	104
Clinical Trials:	9
Patent Applications:	2,155
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for NEOSTIGMINE METHYLSULFATE
What excipients (inactive ingredients) are in NEOSTIGMINE METHYLSULFATE?	NEOSTIGMINE METHYLSULFATE excipients list
DailyMed Link:	NEOSTIGMINE METHYLSULFATE at DailyMed

See drug prices for NEOSTIGMINE METHYLSULFATE

Recent Clinical Trials for NEOSTIGMINE METHYLSULFATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Seoul National University Hospital	N/A
Kasr El Aini Hospital	Phase 4
Alexandria University	Phase 4

See all NEOSTIGMINE METHYLSULFATE clinical trials

Pharmacology for NEOSTIGMINE METHYLSULFATE

Drug Class	Cholinesterase Inhibitor
Mechanism of Action	Cholinesterase Inhibitors

Medical Subject Heading (MeSH) Categories for NEOSTIGMINE METHYLSULFATE

Cholinesterase Inhibitors
Parasympathomimetics

US Patents and Regulatory Information for NEOSTIGMINE METHYLSULFATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	NEOSTIGMINE METHYLSULFATE	neostigmine methylsulfate	SOLUTION;INTRAVENOUS	203629-002	Jan 8, 2015		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Fresenius Kabi Usa	NEOSTIGMINE METHYLSULFATE	neostigmine methylsulfate	SOLUTION;INTRAVENOUS	203629-001	Jan 8, 2015		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Amphastar Pharms Inc	NEOSTIGMINE METHYLSULFATE	neostigmine methylsulfate	SOLUTION;INTRAVENOUS	209933-001	Sep 25, 2017	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Amneal	NEOSTIGMINE METHYLSULFATE	neostigmine methylsulfate	SOLUTION;INTRAVENOUS	210051-001	Jun 15, 2018	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.